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Supplementary Table 2 : Sensitivity of correlation between experimental data and model predictions against identity and size of the unconstrained (evolving) set of reactions. A random set of unconstrained reactions of size 373 (equal to the size used for simulation presented in Figure 4 ), 750, and 1000 was set. The average evolved kcat vector across six replicates per set size was compared to experimental data. Aerobic growth on glucose was used as growth condition. Reactions unchanged after simulation under this constant condition were removed when evolved kcat was below 10 -2 . Note that the number of comparable observations are significantly lower than in the original analysis presented in Figure 4 because of the random nature of the evolving reaction set. The p-values were calculated as described in in the Methods section. Table 3 : Sensitivity of correlation between experimental data and model predictions against the ratio of beneficial mutations to deleterious mutations. The average evolved kcat vector across three replicates per set size was compared to experimental data. Aerobic growth on glucose was used as growth condition (as in Supplementary Figure 11 , where the ratio is 100). We find that the ability of the model to explain experimental data is robust to changes in the assumed frequency of deleterious mutations. The p-values were calculated as described in in the Methods section. Growth rate trajectories of kcat evolution are shown for a randomly chosen set of unconstrained evolving reactions of size 1000, 750, 373 (the number of reactions for which experimental data is available), and an unconstrained set that consists of the 373 reactions for which experimental data was available ("exp_373"). Differences in final growth rates across set sizes are not significant (p>0.76, ANOVA), although this result might be affected by differences in speed of adaptation. Supplementary Figure 8 : Sensitivity of correlation between experimental data and model predictions against identity and size of the unconstrained (evolving) set of reactions. A random set of unconstrained reactions of size 373 (fg_373, equal to the size used for simulation presented in Figure 4 ), 750 (fg_750), and 1000 (fg_1000) was set to simulate kcat evolution across 6 replicates per condition. Predictions are compared to experimental data, where horizontal bars show standard errors across replicates. See Supplementary Table 2 for statistics and details. Supplementary Figure 9 : Sensitivity analysis for size of mutational effects. Growth rate trajectories of kcat evolution are shown for different average mutation effect sizes. The original mean of the log-normal distribution of mutation effects in log scale (log(3/2)≈0.4, see Methods) was increased to 0.5 in three replicates, and decreased to 0.3 in three additional replicates. The correlation of kcat vectors averaged over replicates with in vitro data is R=0.24 (p<0.028) for log(mean)=0.3 and R=0.25 (p<0.021) for log(mean)=0.5. For kapp,max, R=0.55 (p<2e-18) for log(mean)=0.3 and R=0.55 (p<2e-18) for log(mean)=0.5. The p-values were calculated as described in in the Methods section. Supplementary Figure 10 : Magnitude of biochemically constrained kcats determines final growth rates. To determine the effect of the magnitude of constrained kcats on end point growth rates, we simulate three replicates each for the original case (all constrained kcats set to 13.7s -1 ) and for two reduced cases (1.37s -1 and 0.137s -1 ). To speed up convergence and reduce variance across replicates we removed multifunctional reactions as explained in Supplementary Figure 6 . We find that the kcat of the constrained fraction is a major determinant of the final growth rate. Figure 2 . The convergence of replicates in terms of growth rate and kcat suggests a smooth, single-peaked phenotypic fitness landscape. In order to investigate the structure of the fitness landscape between simulated end-points, we average kcat vectors between pairs of replicates and compute the corresponding growth rate. This "hybridization" indicates that no "fitness valleys" exists between end points, supporting the idea of a single-peaked landscape.
Supplementary Figure 13:
Comparison between experimental data and end point kcat predictions from simulations where initial states are sampled from an empirical distribution. Initial kcats of five replicates were drawn from a log-normal distribution with log-scaled mean 19.12s -1 and log-scaled standard deviation 18.88s -1 , as determined from the in vitro data in 2 that could be mapped to the model. To avoid numerical problems in the simulation, values were capped below 1e-3 and above 1e5. Lower correlation than in the original simulations ( Figure 4 ) and over-estimation of experimental data is found. The likely cause for this decreased agreement with experimental data are unrealistically high kcats in initial states, that then have a low probability of deterioration because, even in un-used reactions, decreases in kcats act at best as neutral mutations. Horizontal error bars in show the standard deviation across five simulated replicates. The p-values were calculated as described in in the Methods section. In order to test the effect of network structure and flux distribution on the ability of the model to explain experimental data, we replace stoichiometric coefficients in the metabolic model iJO1366 with integers drawn from a binomial distribution with five trials of success probability ½, where the original sign of the coefficients remains intact. Furthermore, we perturb the flux distribution of the model by replacing the original biomass function of the model with a random sample of consumed components of the same cardinality as the original biomass function (68 metabolites), and with coefficients mimicking the distribution of the original biomass function of the model (normal distribution with mean 1.60 and standard deviation 8.74). This process was repeated until a model with feasible growth was found. Protein molecular weights were set to the median of the model enzymes (=44kDa). kcat evolution was simulated analogously to that presented in Figure 2 , i.e., 5e7 mutations for aerobic growth on glucose were simulated for five replicates with different reaction stoichiometries and biomass functions. Points show averages over these replicates, with error bars showing standard deviations in case more than one replicate showed significant evolution for that reaction. The p-values were calculated as described in in the Methods section. ], green) and one biochemically constrained (E2 [mol gDW -1 ], red) reaction.
Supplementary

The genome-scale simulation assumes optimal gene expression patterns during the adaptation process.
We can impose this assumption by applying a uniform distribution of activities as
Furthermore, a proteome constraint C [mol gDW-1] is applied as
The value of kcat1 [s-1] after n mutations of equal multiplicative effect α is (1)
As kcat2 is constant, E2 is proportional to the systems fitness. When mutations acting on kcat1 are beneficial (α>1), the development of the evolving system with increasing number of mutations takes a sigmoidal shape (Supplementary Fig. 17 ).
Supplementary Also note that with increasing improvement of kcat1 (α>1), the proteome investment into the biophysically constrained second reaction approaches the total proteome C:
Because of the finite population size in real organisms, E2 will not approach C indefinitely; when the fitness gain is too low dynamics become dominated by random drift 3, 4 .
A model of additive mutations
We further analyze a similar model, where mutations act on kcat1 in an additive manner;
This leads to the following expression for E2:
Again, this additive model shows saturation and diminishing returns ( Supplementary Fig. 18 ). Notice that, again, E2,add approaches C as mutations accumulate:
= .
The effect of the number of evolving reactions
To extend the multiplicative model with multiple reactions that act in a linear pathway, we make the simplifying assumption that p evolving reactions share a common kcat, k 0 cat1, while the constrained set of q reactions shares kcat2:
Eevolving denotes the proteome fraction in evolving enzymes, while Econstrained represents the biophysically constrained fraction. Uniform distribution of enzyme activity is applied as:
The protein investment in the constrained fraction is then given by:
As expected, diminishing returns are still occurring, and the total achievable flux of the pathway decreases with the number of constrained reactions ( Supplementary Fig. 19 ).
Supplementary This confirms our intuition: the achievable fitness decreases as the fraction of constrained reactions grows.
A fit of Supplementary Equation 3 to simulated trajectories is shown in Supplementary Figure 3 .
Determinants of the selection coefficient s
We next determine the selection coefficient s for a novel mutation that changes the kcat of one reaction of the evolving set by a factor α. 
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